Glaxosmithkline Pharmaceuticals Ltd

GLAXO06 Dec 2024
Pharmaceuticals
-38.05 (-1.60%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd
Pharmaceuticals
GLAXO06 Dec 2024
-38.05 (-1.60%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Glaxosmithkline Pharmaceuticals Ltd - Share Price & Details

Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
38.95%
Upper Circuit
Lower Circuit
P/E TTM
49.94
P/B Ratio
23.74
Traded Value(Cr)
0.00
EPS TTM
46.98
Book value
Dividend
1.36%

Invest in Glaxosmithkline Pharmaceuticals Ltd at ZERO Brokerage for 30 days

Price Performance

-4.14 %
1 Wk
-10.89 %
1 M
-17.25 %
3 M
38.95 %
1 Y
20.07 %
YTD

Traded Volume Movement

Technical Details

Support 3
2252
Support 2
2293
Support 1
2318
Pivot Point :
2359
Resistance 1
2384
Resistance 2
2425
Resistance 3
2450

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Glaxosmithkline Pharmaceuticals Ltd
₹2,343.15(-38.05/-1.60%)
2,343.15-38.0539,694.3738.9549.9423.74
Lupin Ltd
₹2,133.55(+8.50/0.40%)
2,133.55+8.5097,332.0371.5832.454.43
Ipca Laboratories Ltd
₹1,538.20(+44.85/3.00%)
1,538.20+44.8539,024.7836.5555.915.79
J B Chemicals & Pharmaceuticals Ltd
₹1,763.95(-14.80/-0.83%)
1,763.95-14.8027,413.5018.2945.688.68
388.85+0.552,282.76-13.1622.841.38
Sanofi India Ltd
₹6,242.30(-39.65/-0.63%)
6,242.30-39.6514,376.02-24.0134.0820.99

About Glaxosmithkline Pharmaceuticals Ltd

Glaxosmithkline Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 39749.43 crores. It has reported a sales of Rs. 1000.05 crores and a net profit of Rs. 248.69 crores for the quarter ended December 2018. The company management includes Renu S Karnad, D Sundaram,A A Nadkarni,P V Bhide,A N Roy,Subesh Williams,Renu S Karnad,Sunita Maheshwari,Manu Anand,Bhushan Akshikar,J. Chandy (Glaxosmithkline Pharmaceuticals Ltd) among others.
Chairman
Renu S Karnad
Registered office
GSK House,Dr Annie Besant Road Worli,Mumbai,Maharashtra,400030
FAX :91-022-24959494
Background
Incorporation Year1924
Face Value₹10
Market Lot1

Latest News

Penny stock turns multibagger! ₹1 lakh becomes ₹1.68 crore in 5-year

Praveg shares are one of the multibagger stocks the Indian stock market has produced in recent years. In the last five years, Praveg's share price has risen from ₹4.34 per apiece to ₹730 per share, delivering a whopping 15,700 per cent returns to its positional shareholders. So, if an investor had invested ₹1 lakh in this stock five years ago, its ₹1 lakh would have turned to ₹1.68 crore.
07 Dec 2024 | 03:45 PM

Paytm Singapore to sell stock acquisition rights in PayPay for Rs 2,364 cr

Paytm's subsidiary, One97 Communications Singapore, has sold its Stock Acquisition Rights in Japan's PayPay Corporation to SoftBank Vision Fund 2 for approximately Rs 2,364 crore, with proceeds to strengthen Paytm's cash reserves and support future initiatives. The sale is expected to be completed by December 2024, with Paytm to continue its partnership with PayPay.
07 Dec 2024 | 02:37 PM

Bajaj Healthcare get approval from Australian agency for manufacturing site

Bajaj Healthcare's API manufacturing site in Savli, Vadodara, Gujarat, has received approval from the Therapeutic Goods Administration (TGA) of Australia.This site, already approved by the USFDA and the European Union, is now authorised to supply active pharmaceutical ingredients (APIs) directly to the Australian and New Zealand markets. The approval is valid for 24 months.
07 Dec 2024 | 12:44 PM

Multibagger SME IPO turns ₹1.40 lakh to ₹5.49 lakh in two years

Bonus shares, stock split effect: Investing in stocks is like investing in a business. Rhetan TMT shares, listed on the BSE SME platform in 2022, declared a 1:10 stock split and 11:4 bonus shares in 2023, resulting in a significant increase in shareholding from 2000 to 25,500, and a surge in value from ₹1.40 lakh to ₹5.49 lakh.
07 Dec 2024 | 12:01 PM

8 stocks nearing ex-dates for dividend, bonus, split next week

Shareholders who purchase the stock at least one day before the ex-date are eligible for dividends, as the settlement occurs the following day. However, those buying the stock on the ex-date will not qualify for dividends, splits, bonus issues, or similar benefits. Exxaro Tiles and other companies will be in focus next week as they approach record dates for dividends, bonus issues & stock splits.
07 Dec 2024 | 12:00 PM

How to buy Glaxosmithkline Pharmaceuticals Ltd shares on nse?

To buy Glaxosmithkline Pharmaceuticals Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Glaxosmithkline Pharmaceuticals Ltd share price today?

The Glaxosmithkline Pharmaceuticals Ltd shares price on nse is Rs.2343.15 today.

What is the market cap of Glaxosmithkline Pharmaceuticals Ltd shares on NSE ?

The company has a market capitalization of Rs.39694.37Cr

What is the PE & PB ratio of Glaxosmithkline Pharmaceuticals Ltd shares ?

PE is 49.94 and PB is 23.74

What is the 52 Week High and Low of Glaxosmithkline Pharmaceuticals Ltd shares?

Glaxosmithkline Pharmaceuticals Ltd stock price high: Rs.3088 Glaxosmithkline Pharmaceuticals Ltd stock price low: Rs.1661.35

What is the correct way to invest in Glaxosmith?

The correct way to invest in GlaxoSmithKline Pharmaceuticals is to buy the shares of the company through a reputed broker like Motilal Oswal. You can sign up with the broker online and open a dreamt and trading account first. Then, you can place an order to buy the company stock through the broker and invest in the company. 

How can I sell Glaxosmith Pharma shares?

To sell GlaxoSmithKline Pharmaceutical shares you must be signed up with a broker like Motilal Oswal. Shares must be held in a demat account to be sold. You also need to have a trading account linked to your demat account. Once you place a sell request with your broker, your shares are sold and the proceeds are credited to your bank account linked with your demat and trading accounts. 

What is the ROI of Glaxosmith Pharma shares?

The current year ROI (YTD 17 April 2023) of GlaxoSmithKline Pharmaceutical shares is -3.81%. 

Can I buy Glaxosmith Pharma shares now?

You can buy the shares of GlaxoSmithKline Pharmaceuticals now or at any time through a reputed broker like Motilal Oswal. All you require is a demat account linked with a trading account. These two accounts are connected to your bank account and you can easily place a buy order with your broker to buy the shares you want. 

What is the trending volume of Glaxosmith Pharma shares?

The trading volume of GlaxoSmithKline Pharmaceutical shares is 53,700 (17 April 2023).